Neurocrine Biosciences Inc SEC filings NBIX
Neurocrine Biosciences Inc has 1,000 filings in SEC EDGAR's recent list, going back to Feb 8, 2018. Its latest annual report, Form ARS, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 2, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 2, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2026 | Nov 2, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 28, 2026 | Sep 25, 2026 |
| S-8 | Employee stock plan registration | Jul 31, 2026 | — |
| 8-K/A | Amended current report | Jul 31, 2026 | May 14, 2026 |
| 10-Q | Quarterly report | Jul 31, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 30, 2026 | Jul 30, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 28, 2026 | May 27, 2026 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, New debt, Regulation FD disclosure
|
May 18, 2026 | May 14, 2026 |
| SC TO-T/A | Filing | May 18, 2026 | — |
| 10-Q | Quarterly report | May 5, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 5, 2026 | May 5, 2026 |
| SC TO-T/A | Filing | Apr 29, 2026 | — |
| SC TO-T/A | Filing | Apr 28, 2026 | — |
| SC TO-T | Filing | Apr 20, 2026 | — |
| ARS | Annual report to shareholders | Apr 15, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 15, 2026 | — |
| DEF 14A | Proxy statement | Apr 15, 2026 | Apr 15, 2026 |
| SC TO-C | Filing | Apr 7, 2026 | — |
| SC TO-C | Filing | Apr 6, 2026 | — |
| SC TO-C | Filing | Apr 6, 2026 | — |
| 8-K |
Current report
Material agreement
|
Apr 6, 2026 | Apr 5, 2026 |
| 10-K | Annual report | Feb 11, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 11, 2026 | Feb 11, 2026 |
| 8-K |
Current report
Officer or director change
|
Nov 24, 2025 | Nov 21, 2025 |
| 10-Q | Quarterly report | Oct 28, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Oct 28, 2025 | Oct 28, 2025 |
| 10-Q | Quarterly report | Jul 30, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Jul 30, 2025 | Jul 30, 2025 |
| 8-K |
Current report
Officer or director change
|
May 30, 2025 | May 30, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 22, 2025 | May 21, 2025 |
| S-8 POS | Filing | May 21, 2025 | — |
| S-8 POS | Filing | May 21, 2025 | — |
| S-8 POS | Filing | May 21, 2025 | — |
| S-8 POS | Filing | May 21, 2025 | — |
| S-8 POS | Filing | May 21, 2025 | — |
| S-8 POS | Filing | May 21, 2025 | — |
| S-8 POS | Filing | May 21, 2025 | — |
| S-8 POS | Filing | May 21, 2025 | — |
| S-8 POS | Filing | May 21, 2025 | — |
| S-8 POS | Filing | May 21, 2025 | — |
| S-8 POS | Filing | May 21, 2025 | — |
| S-8 POS | Filing | May 21, 2025 | — |
| S-8 | Employee stock plan registration | May 21, 2025 | — |
| 10-Q | Quarterly report | May 5, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 5, 2025 | May 5, 2025 |
| ARS | Annual report to shareholders | Apr 9, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 9, 2025 | — |
| DEF 14A | Proxy statement | Apr 9, 2025 | Apr 9, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 4, 2025 | Apr 2, 2025 |
| 10-K | Annual report | Feb 10, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 6, 2025 | Feb 6, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 27, 2025 | Jan 24, 2025 |
| 8-K |
Current report
Other events
|
Dec 20, 2024 | Dec 20, 2024 |
| 8-K |
Current report
Other events
|
Nov 1, 2024 | Oct 31, 2024 |
| 10-Q | Quarterly report | Oct 30, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Oct 30, 2024 | Oct 30, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 11, 2024 | Oct 11, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 28, 2024 | Aug 28, 2024 |
| S-8 | Employee stock plan registration | Aug 1, 2024 | — |
| 10-Q | Quarterly report | Aug 1, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 1, 2024 | Aug 1, 2024 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
May 28, 2024 | May 24, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 23, 2024 | May 22, 2024 |
| 10-Q | Quarterly report | May 1, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 1, 2024 | May 1, 2024 |
| ARS | Annual report to shareholders | Apr 10, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 10, 2024 | — |
| DEF 14A | Proxy statement | Apr 10, 2024 | May 22, 2024 |
| 10-K | Annual report | Feb 9, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 7, 2024 | Feb 7, 2024 |
| 8-K |
Current report
Other events
|
Nov 13, 2023 | Nov 10, 2023 |
| 8-K |
Current report
Other events
|
Nov 9, 2023 | Nov 9, 2023 |
| 10-Q | Quarterly report | Oct 31, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Oct 31, 2023 | Oct 31, 2023 |
| 8-K |
Current report
Other events
|
Oct 6, 2023 | Oct 5, 2023 |
| 8-K |
Current report
Other events
|
Oct 5, 2023 | Oct 5, 2023 |
| 8-K |
Current report
Other events
|
Sep 12, 2023 | Sep 12, 2023 |
| S-8 | Employee stock plan registration | Aug 1, 2023 | — |
| 10-Q | Quarterly report | Aug 1, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 1, 2023 | Aug 1, 2023 |
| 8-K |
Current report
Officer or director change
|
Jul 13, 2023 | Jul 10, 2023 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Jul 12, 2023 | Jul 11, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 19, 2023 | May 17, 2023 |
| 10-Q | Quarterly report | May 3, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 3, 2023 | May 3, 2023 |
| DEFA14A | Additional proxy material | May 2, 2023 | — |
| ARS | Annual report to shareholders | Apr 6, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 5, 2023 | — |
| DEF 14A | Proxy statement | Apr 5, 2023 | — |
| 8-K |
Current report
Other events
|
Mar 29, 2023 | Mar 28, 2023 |
| 8-K |
Current report
Other events
|
Feb 24, 2023 | Feb 21, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Feb 10, 2023 | Feb 10, 2023 |
| 10-K | Annual report | Feb 9, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 6, 2023 | Feb 6, 2023 |
| 8-K |
Current report
Material agreement
|
Jan 9, 2023 | Jan 8, 2023 |
| 10-Q | Quarterly report | Nov 1, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 1, 2022 | Nov 1, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 30, 2022 | Aug 30, 2022 |
| S-8 | Employee stock plan registration | Aug 4, 2022 | — |
| 10-Q | Quarterly report | Aug 4, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2022 | Aug 4, 2022 |
| 8-K |
Current report
Other events
|
Jun 1, 2022 | May 31, 2022 |
| 8-K |
Current report
Other events
|
May 25, 2022 | May 24, 2022 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 23, 2022 | May 18, 2022 |
| 10-Q | Quarterly report | May 4, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 4, 2022 | May 4, 2022 |
| DEFA14A | Additional proxy material | Apr 7, 2022 | — |
| DEF 14A | Proxy statement | Apr 7, 2022 | May 18, 2022 |
| 10-K | Annual report | Feb 11, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 11, 2022 | Feb 11, 2022 |
| CT ORDER | Filing | Jan 18, 2022 | — |
| 8-K |
Current report
Results of operations
|
Jan 6, 2022 | Jan 6, 2022 |
| CT ORDER | Filing | Dec 30, 2021 | — |
| 8-K |
Current report
Other events
|
Dec 23, 2021 | Dec 22, 2021 |
| 8-K |
Current report
Material agreement
|
Nov 22, 2021 | Nov 22, 2021 |
| UPLOAD | Letter from the SEC | Nov 15, 2021 | — |
| CORRESP | Letter to the SEC | Nov 3, 2021 | — |
| 10-Q | Quarterly report | Nov 1, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 1, 2021 | Nov 1, 2021 |
| UPLOAD | Letter from the SEC | Oct 27, 2021 | — |
| CORRESP | Letter to the SEC | Oct 5, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 22, 2021 | — |
| 10-Q | Quarterly report | Aug 3, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2021 | Aug 3, 2021 |
| 8-K |
Current report
Shareholder vote results
|
May 21, 2021 | May 19, 2021 |
| 10-Q | Quarterly report | May 5, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 5, 2021 | May 5, 2021 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Apr 16, 2021 | Apr 15, 2021 |
| DEFA14A | Additional proxy material | Apr 9, 2021 | — |
| DEF 14A | Proxy statement | Apr 9, 2021 | May 19, 2021 |
| 10-K | Annual report | Feb 5, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Feb 4, 2021 | Feb 4, 2021 |
| 8-K |
Current report
Other events
|
Feb 2, 2021 | Feb 2, 2021 |
| 8-K |
Current report
Results of operations
|
Jan 8, 2021 | Jan 8, 2021 |
| 8-K |
Current report
Other events
|
Nov 24, 2020 | Nov 23, 2020 |
| 8-K |
Current report
Other events
|
Nov 19, 2020 | Nov 18, 2020 |
| 10-Q | Quarterly report | Nov 9, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2020 | Nov 9, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 10, 2020 | Sep 9, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Aug 28, 2020 | Aug 28, 2020 |
| S-8 POS | Filing | Aug 3, 2020 | — |
| S-8 | Employee stock plan registration | Aug 3, 2020 | — |
| 10-Q | Quarterly report | Aug 3, 2020 | Jun 30, 2020 |
| 8-K | Current report | Aug 3, 2020 | Aug 3, 2020 |
| 8-K |
Current report
Other events
|
Jul 28, 2020 | Jul 28, 2020 |
| 8-K |
Current report
Other events
|
Jul 13, 2020 | Jul 13, 2020 |
| 8-K |
Current report
Material agreement
|
Jun 16, 2020 | Jun 12, 2020 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 21, 2020 | May 19, 2020 |
| 10-Q | Quarterly report | May 6, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations
|
May 6, 2020 | May 6, 2020 |
| DEFA14A | Additional proxy material | Apr 9, 2020 | — |
| DEF 14A | Proxy statement | Apr 9, 2020 | May 19, 2020 |
| 8-K |
Current report
Officer or director change
|
Apr 9, 2020 | Apr 6, 2020 |
| 10-K | Annual report | Feb 7, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Feb 5, 2020 | Feb 4, 2020 |
| 8-K |
Current report
Results of operations, Officer or director change, Bylaw or fiscal year change
|
Feb 4, 2020 | Feb 1, 2020 |
| 8-K |
Current report
Results of operations
|
Jan 13, 2020 | Jan 12, 2020 |
| S-8 | Employee stock plan registration | Nov 5, 2019 | — |
| 10-Q | Quarterly report | Nov 4, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2019 | Nov 4, 2019 |
| CT ORDER | Filing | Sep 27, 2019 | — |
| 8-K |
Current report
Officer or director change
|
Sep 11, 2019 | Sep 11, 2019 |
| 10-Q | Quarterly report | Jul 29, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Results of operations
|
Jul 29, 2019 | Jul 29, 2019 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 23, 2019 | May 22, 2019 |
| 10-Q | Quarterly report | Apr 29, 2019 | Mar 31, 2019 |
| 8-K |
Current report
Results of operations
|
Apr 29, 2019 | Apr 29, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 26, 2019 | Apr 26, 2019 |
| DEF 14A | Proxy statement | Apr 17, 2019 | May 22, 2019 |
| CT ORDER | Filing | Mar 19, 2019 | — |
| 10-K | Annual report | Feb 8, 2019 | Dec 31, 2018 |
| 8-K |
Current report
Results of operations
|
Feb 5, 2019 | Feb 5, 2019 |
| 8-K |
Current report
Material agreement
|
Jan 29, 2019 | Jan 28, 2019 |
| 8-K |
Current report
Results of operations
|
Jan 7, 2019 | Jan 6, 2019 |
| 8-K |
Current report
Other events
|
Dec 12, 2018 | Dec 12, 2018 |
| 10-Q | Quarterly report | Nov 5, 2018 | Sep 30, 2018 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2018 | Nov 5, 2018 |
| 8-K |
Current report
Officer or director change
|
Sep 24, 2018 | Sep 18, 2018 |
| S-8 | Employee stock plan registration | Aug 22, 2018 | — |
| 8-K |
Current report
Results of operations
|
Aug 3, 2018 | Jul 31, 2018 |
| 10-Q | Quarterly report | Jul 31, 2018 | Jun 30, 2018 |
| 8-K |
Current report
Results of operations
|
Jul 31, 2018 | Jul 31, 2018 |
| 8-K |
Current report
Other events
|
Jul 24, 2018 | Jul 24, 2018 |
| CT ORDER | Filing | Jun 5, 2018 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 30, 2018 | May 24, 2018 |
| CT ORDER | Filing | May 8, 2018 | — |
| 10-Q | Quarterly report | Apr 30, 2018 | Mar 31, 2018 |
| 8-K |
Current report
Results of operations
|
Apr 30, 2018 | Apr 30, 2018 |
| DEFA14A | Additional proxy material | Apr 4, 2018 | — |
| DEF 14A | Proxy statement | Apr 4, 2018 | May 24, 2018 |
| CT ORDER | Filing | Feb 16, 2018 | — |
| 8-K |
Current report
Other events
|
Feb 14, 2018 | Feb 14, 2018 |
| S-8 | Employee stock plan registration | Feb 14, 2018 | — |
| 10-K | Annual report | Feb 13, 2018 | Dec 31, 2017 |
| 8-K |
Current report
Results of operations
|
Feb 13, 2018 | Feb 13, 2018 |
| 8-K |
Current report
Officer or director change
|
Feb 9, 2018 | Feb 5, 2018 |
Showing 197 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- NBIX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 914475
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.